APA

Steeneck C., Kinzel O., Anderhub S., Hornberger M., Pinto S., Morschhaeuser B., Braun F., Kleymann G. & Hoffmann T. (2020). Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. : ACS medicinal chemistry letters.

Chicago

Steeneck Christoph, Kinzel Olaf, Anderhub Simon, Hornberger Martin, Pinto Sheena, Morschhaeuser Barbara, Braun Floriane, Kleymann Gerald and Hoffmann Thomas. 2020. Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. : ACS medicinal chemistry letters.

Harvard

Steeneck C., Kinzel O., Anderhub S., Hornberger M., Pinto S., Morschhaeuser B., Braun F., Kleymann G. and Hoffmann T. (2020). Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. : ACS medicinal chemistry letters.

MLA

Steeneck Christoph, Kinzel Olaf, Anderhub Simon, Hornberger Martin, Pinto Sheena, Morschhaeuser Barbara, Braun Floriane, Kleymann Gerald and Hoffmann Thomas. Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. : ACS medicinal chemistry letters. 2020.